Dr. Abdul Alim Khan

BEXIMCO PHARMACEUTICALS LTD.

1st October, 2013

Dr. Abdul Alim Khan

Beximco Pharmaceuticals Limited ("BPL" or "Company"; AIM Symbol: BXP) today reports with sadness the death of Dr. Abdul Alim Khan on 29 September 2013. He had been serving as a Non-executive Director of Beximco Pharmaceuticals since 1986.

Ahmed Sohail Fasiur Rahman, Chairman of Beximco Pharmaceuticals, said: "It is with a deep sense of grief and profound sorrow we have learnt the sad demise of Dr. Abdul Alim Khan. We have no words to console his nearest and dearest ones at this moment. We extend our deepest sympathy and sincerest condolences to the bereaved members of his family. We pray to the Almighty Allah to grant him eternal peace and salvation of the departed soul and to give the members of his family the strength to withstand this irreparable loss with courage and fortitude."

For further information please visit www.beximco-pharma.com or enquire to:

Beximco Pharma

Nazmul Hassan MP, Managing Director

Tel: +880 2 861 9151, ext.20080

Md. Asad Ullah, FCS, Executive Director & Company Secretary

Tel: +880 2 8618220-1, Ext 10140

Libertas Capital Corporate Finance (Nomad)

Thilo Hoffmann

Tel: +44 (0)20 7569 9650

Daniel Stewart & Company (Broker)

Paul Shackleton

James Thomas

Tel: +44 (0)20 7776 6550

FTI Consulting

Simon Conway / Susan Stuart / Victoria Foster-Mitchell

Tel: +44 (0)20 7269 7169

Notes to Editors

About Beximco Pharmaceuticals Limited

Founded in 1976 and based in Dhaka, Bangladesh, Beximco Pharma manufactures and sells generic pharmaceutical formulation products and active pharmaceutical ingredients. The Company also undertakes contract manufacturing for multinational and leading global generic pharmaceutical companies. The Company operates from a 23 acre site in Dhaka and has manufacturing facilities for producing various drugs in different delivery systems such as tablets, capsules, liquids, semi-solids, intravenous fluids, metered dose inhalers, dry powder inhalers, sterile ophthalmic drops, prefilled syringes, injectables, nebulizer solutions etc. Ensuring access to quality medicines is the powerful aspiration that motivates 2,700 employees of the Company.

Beximco Pharma's state-of-the-art manufacturing facilities are certified by global regulatory authorities of Australia, European Union, Gulf nations, and Brazil, among others. The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in Africa, including Mauritius, Kenya, Ghana and Nigeria, Pacific Island and Latin & Central American countries, Middle East and South East Asia, including Singapore, Malaysia, Philippines and Hong Kong.